logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jianyin Zhou

fujian medical university
H指数:17
被引数:1,035

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glucose starvation mimetic aldometanib removes immune barriers permitting mice with hepatocellular carcinoma to live to normal ages

葡萄糖饥饿模拟aldometanib消除免疫屏障，使肝细胞癌小鼠能够活到正常年龄

Cell Research
IF25.9
2025-11-250
OAAI
Hui-Hui Hu; Xuefeng Wang; Bin Lan; Haili Cheng; Hong Wen; Fangfang Chen; Jianfeng Wu; Mengqi Li; Jiazhou Chen; Jinhui Zhang; Dongxu Chen; Shiyu Lin; Jieyu Lin; Mingyang Yang; Zhenhua Wu; Zhong-Zheng Zheng; Fuqing Chen; Jianyin Zhou; Gang Chen; Yu Chen; Xianming Deng; Chen-Song Zhang; Jingfeng Liu; Sheng-Cai Lin
Long-term survival in advanced unresectable HCC treated with transcatheter arterial chemoembolization combined with lenvatinib and PD-1 inhibitors

晚期不可切除HCC患者接受经导管动脉化疗栓塞联合仑伐替尼和PD-1抑制剂治疗后的长期生存

ONCOLOGIST
IF4.2
2025-06-010
PRE
Zeng, Zhen-Xin; Song, Hua-Chun; Li, Yi-Nan; Wu, Jia-Yi; Liang, Dong; Li, Shu-Qun; Zhang, Zhi-Bo; Zhuang, Shao-Wu; Li, Bin; Zhou, Jian-Yin; Liu, De-Yi; Li, Han; Ou, Xiang-Ye; Pan, Rong-Jian; Wu, Jun-Yi; Yan, Mao-Lin
Predictors of short- and long-term survival in unresectable hepatocellular carcinoma (uHCC) treated with transcatheter arterial chemoembolization combined with lenvatinib plus PD-1 inhibitors: a multicenter retrospective study

不可切除肝细胞癌(uHCC)经导管动脉化疗栓塞联合仑伐替尼加PD-1抑制剂治疗后短期及长期生存的预测因素：一项多中心回顾性研究

LANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
2025-02-010
OAAI
Zeng, Zhen-Xin; Li, Yi-Nan; Song, Hua-Chun; Wu, Jia-Yi; Li, Shu-Qun; Zhang, Zhi-Bo; Zhuang, Shao-Wu; Li, Bin; Zhou, Jian-Yin; Liu, De-Yi; Li, Han; Ou, Xiang-Ye; Pan, Rong-Jian; Wu, Jun-Yi; Yan, Mao-Lin
Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study

辅助治疗持续时间对初始不可切除肝细胞癌经转化手术治疗患者的影响：一项倾向评分匹配研究

JOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
2024-09-010
OAAI
Lin, Zhong-Tai; Wei, Shao-Ming; Wu, Jun-Yi; Zhang, Zhi-Bo; Wang, Shuang-Jia; Zhou, Jian-Yin; Luo, Meng-Chao; Zeng, Zhen-Xin; Ou, Xiang-Ye; Fu, Yang-Kai; Li, Han; Liu, De-Yi; Wu, Jia-Yi; Yan, Mao-Lin
Low glucose metabolite 3-phosphoglycerate switches PHGDH from serine synthesis to p53 activation to control cell fate

低葡萄糖代谢物3-磷酸甘油酸将PHGDH从丝氨酸合成转换为p53激活以控制细胞命运

CELL RESEARCH
IF25.9
2023-09-1912
OAAI
Wu, Yu-Qing; Zhang, Chen-Song; Xiong, Jinye; Cai, Dong-Qi; Wang, Chen-Zhe; Wang, Yu; Liu, Yan-Hui; Wang, Yu; Li, Yiming; Wu, Jian; Wu, Jianfeng; Lan, Bin; Wang, Xuefeng; Chen, Siwei; Cao, Xianglei; Wei, Xiaoyan; Hu, Hui-Hui; Guo, Huiling; Yu, Yaxin; Ghafoor, Abdul; Xie, Changchuan; Wu, Yaying; Xu, Zheni; Zhang, Cixiong; Zhu, Mingxia; Huang, Xi; Sun, Xiufeng; Lin, Shu-Yong; Piao, Hai-Long; Zhou, Jianyin; Lin, Sheng-Cai
Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

来伐替尼联合Anti-PD-1抗体联合肝动脉化疗栓塞治疗不可切除肝癌的多中心回顾性研究

JOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
2021-10-01108
OAAI
Wu, Jia-Yi; Yin, Zhen-Yu; Bai, Yan-Nan; Chen, Yu-Feng; Zhou, Song-Qiang; Wang, Shuang-Jia; Zhou, Jian-Yin; Li, Yi-Nan; Qiu, Fu-Nan; Li, Bin; Yan, Mao-Lin

研究方向

暂未获取到该数据
严
严茂林
H 指数:18论文数:99被引数:1,163
J
Jiayi Wu
H 指数:26论文数:238被引数:3,096
Z
Zhi‐Bo Zhang
H 指数:10论文数:52被引数:448
Z
Zhen-Xin Zeng
H 指数:6论文数:20被引数:151
Y
Yinan Li
H 指数:22论文数:113被引数:1,587
李
李彬
H 指数:46论文数:186被引数:7,500
J
Junyi Wu
H 指数:19论文数:107被引数:1,598
S
Shu-Qun Li
H 指数:9论文数:28被引数:214
D
De-Yi Liu
H 指数:12论文数:47被引数:563
W
Wu, Jun-Yi
H 指数:0论文数:18被引数:2